Ignite Creation Date:
2024-05-05 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 9:52 AM
Study NCT ID:
NCT00718536
Status:
COMPLETED
Last Update Posted:
2019-12-05
First Post:
2008-07-16
Brief Title:
Clinical Trial Assessing Once Daily Raltegravir Administration 800 mg QD in HIV-1-Infected Patients Receiving Unboosted Atazanavir 400 mg QD- Based Antiretroviral Therapy
Sponsor:
Germans Trias i Pujol Hospital
Organization:
Germans Trias i Pujol Hospital
Organization Data
Organization:
Germans Trias i Pujol Hospital
Class:
OTHER
Study ID:
RALqd-ATV
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Germans Trias i Pujol Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Fundación FLS de Lucha Contra el Sida las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | OTHER |